Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.FURTHER restrictions on NHS prescribing and an end to the secrecy surrounding drug price control and profits of the pharmaceutical industry were called for yesterday, in a report from the all-party House of Commons Health Committee, which also criticised prescription charges as 'too high,' writes Liz Hunt.
The report proposes an overhaul of the present system of controlling the NHS drug budget which, the committee believes, favours drug companies.
The central recommendation is the introduction of a national prescribing list of drugs for all illnesses, which the NHS is prepared to pay for because they have proved their cost-effectiveness or therapeutic value. Scores of expensive drugs, no more effective than cheaper alternatives, would be excluded.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments